The early mortality in patients with hip fractures from bony metastases is unknown. The objectives of this study were to quantify 30- and 90-day mortality in patients with proximal femoral metastases, and to create a mortality prediction tool based on biomarkers associated with early death. This was a retrospective cohort study of consecutive patients referred to the orthopaedic department at a UK trauma centre with a proximal femoral metastasis (PFM) over a seven-year period (2010 to 2016). The study group were compared to a matched control group of non-metastatic hip fractures. Minimum follow-up was one year.Aims
Methods
Blood tests including liver function tests (LFTs), C-reactive protein (CRP), coagulation screens and international normalising ratios (INR) are frequently requested investigations that complement the surgical and anaesthetic pre-operative assessment of patients. The paucity of guidance available for blood requesting in acute trauma and orthopaedic admissions can lead to inappropriate requesting practices and over investigation. Unnecessary tests place an economic burden on a hospital and repeated venepuncture is unpleasant for patients. We audited blood requesting practices and with multidisciplinary input developed guidelines to improve practice which were subsequently implemented. Admissions over a period of one month to Ninewells Hospital and Perth Royal Infirmary were audited retrospectively. The frequency and clinical indications for LFTs, coagulation screens/INR and CRP for the duration of the patient's admission were recorded. Re-audit was carried out for one month after the introduction of the guidelines. 216 patients were included in January and 236 patients in September 2014. Total no. of LFTs requested: January 895, September 336 (−62.5%). Total no of coagulation screens/INR requested: January 307, September 210 (−31.6%). Total number of CRPs requested: January 894, September 317 (−64.5%). No. of blood requests per patient: January (M=4.81, SD 4.75), September (M=3.60, SD = 4.70). A significant decrease was observed in admission requesting and subsequent monitoring (p<0.01) for LFTs, coagulation screens/INR, CRP when the guidance was introduced. The implementation of the bloods guidance resulted in a large reduction in admission requesting and subsequent monitoring without incident. The cost of investigation was significantly reduced, as were venepuncture rates.
